It is reported that chitosan and its derivatives down-regulate AKT phosphorylation in a dose-dependent manner and being used to block AKT activities in different cancer types (Liu et al., 2011; Xiong et al., 2018; Amirani et al., 2020; Fang et al., 2021). This evidence concerns the gene AKT1 and cancer.